Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings.

Behçet disease Endoscopy Intestinal diseases Ulcer Ultrasonography

Journal

Intestinal research
ISSN: 1598-9100
Titre abrégé: Intest Res
Pays: Korea (South)
ID NLM: 101572802

Informations de publication

Date de publication:
16 Jul 2024
Historique:
received: 25 09 2023
accepted: 26 02 2024
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 15 7 2024
Statut: aheadofprint

Résumé

Intestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports have compared intestinal ultrasound with endoscopic ulcer activity or histopathological findings for intestinal Behçet disease. We evaluated the usefulness of intestinal ultrasound for assessing the activity of ileocecal ulcers in intestinal Behçet disease. We retrospectively compared intestinal ultrasound findings with 73 corresponding endoscopic images and 6 resected specimens. The intestinal ultrasound findings were assessed for 7 parameters (bowel wall thickness, vascularity [evaluated using the modified Limberg score with color Doppler], bowel wall stratification, white-plaque sign [strong hyperechogenic lines or spots], mesenteric lymphadenopathy, extramural phlegmons, and fistulas), and endoscopic ulcer activity was classified into active, healing, and scar stages. Histopathological findings were evaluated by consensus among experienced pathologists. Bowel wall thickness (P< 0.001), vascularity (P< 0.001), loss of bowel wall stratification (P= 0.015), and white-plague sign (P= 0.013) were significantly exacerbated in the endoscopic active ulcer stage. Receiver operating characteristic curve analysis revealed that a bowel wall thickness of > 5.5 mm (sensitivity 89.7%, specificity 85.3%) was potentially useful for detecting active lesions. When compared with histopathological findings, an increase in bowel wall thickness reflected the ulcer marginal ridge, and the white-plaque sign reflected the ulcer bottom. Intestinal ultrasound is useful for monitoring intestinal ulcer activity in intestinal Behçet disease.

Sections du résumé

Background/Aims UNASSIGNED
Intestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports have compared intestinal ultrasound with endoscopic ulcer activity or histopathological findings for intestinal Behçet disease. We evaluated the usefulness of intestinal ultrasound for assessing the activity of ileocecal ulcers in intestinal Behçet disease.
Methods UNASSIGNED
We retrospectively compared intestinal ultrasound findings with 73 corresponding endoscopic images and 6 resected specimens. The intestinal ultrasound findings were assessed for 7 parameters (bowel wall thickness, vascularity [evaluated using the modified Limberg score with color Doppler], bowel wall stratification, white-plaque sign [strong hyperechogenic lines or spots], mesenteric lymphadenopathy, extramural phlegmons, and fistulas), and endoscopic ulcer activity was classified into active, healing, and scar stages. Histopathological findings were evaluated by consensus among experienced pathologists.
Results UNASSIGNED
Bowel wall thickness (P< 0.001), vascularity (P< 0.001), loss of bowel wall stratification (P= 0.015), and white-plague sign (P= 0.013) were significantly exacerbated in the endoscopic active ulcer stage. Receiver operating characteristic curve analysis revealed that a bowel wall thickness of > 5.5 mm (sensitivity 89.7%, specificity 85.3%) was potentially useful for detecting active lesions. When compared with histopathological findings, an increase in bowel wall thickness reflected the ulcer marginal ridge, and the white-plaque sign reflected the ulcer bottom.
Conclusions UNASSIGNED
Intestinal ultrasound is useful for monitoring intestinal ulcer activity in intestinal Behçet disease.

Identifiants

pubmed: 39009376
pii: ir.2023.00129
doi: 10.5217/ir.2023.00129
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Katsuki Yaguchi (K)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Reiko Kunisaki (R)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Sho Sato (S)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Kaori Hirai (K)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Misato Izumi (M)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Yoshimi Fukuno (Y)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Mami Tanaka (M)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Mai Okazaki (M)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Rongrong Wu (R)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Yurika Nishikawa (Y)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Yusuke Matsune (Y)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Shunsuke Shibui (S)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Yoshinori Nakamori (Y)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Masafumi Nishio (M)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Mao Matsubayashi (M)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Tsuyoshi Ogashiwa (T)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Ayako Fujii (A)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Kenichiro Toritani (K)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Hideaki Kimura (H)

Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.

Eita Kumagai (E)

Department of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.

Yukiko Sasahara (Y)

Department of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.

Yoshiaki Inayama (Y)

Department of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.

Satoshi Fujii (S)

Department of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Department of Molecular Pathology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Toshiaki Ebina (T)

Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan.

Kazushi Numata (K)

Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.
Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.

Shin Maeda (S)

Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan.

Classifications MeSH